TCT-1021 Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk.

MLA

Hikida, Ryo, et al. “TCT-1021 Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk.” Journal of the American College of Cardiology (JACC), vol. 84, no. 18, Oct. 2024, p. B438. EBSCOhost, https://doi.org/10.1016/j.jacc.2024.09.1214.

APA

Hikida, R., Ozaki, Y., Katayama, Y., Takahata, M., Wada, T., Taruya, A., Satogami, K., Shiono, Y., Kuroi, A., Yamano, T., Kitabata, H., & Tanaka, A. (2024). TCT-1021 Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk. Journal of the American College of Cardiology (JACC), 84(18), B438. https://doi.org/10.1016/j.jacc.2024.09.1214

Chicago

Hikida, Ryo, Yuichi Ozaki, Yosuke Katayama, Masahiro Takahata, Teruaki Wada, Akira Taruya, Keisuke Satogami, et al. 2024. “TCT-1021 Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk.” Journal of the American College of Cardiology (JACC) 84 (18): B438. doi:10.1016/j.jacc.2024.09.1214.